Synthesis, Anticancer Activity, and Molecular Docking of New 1,2,3-Triazole Linked Tetrahydrocurcumin Derivatives
Molecules · 25.06.2024 · 29 (13) · 3010
DOI: 10.3390/molecules29133010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 25.06.2024. Verfasst von Meitao Duan und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Xiamen Medical College, Xiamen 361023, China. Hauptthemen laut MEDLINE: Curcumin, Molecular Docking Simulation, Antineoplastic Agents, Triazoles. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Project of Xiamen Medical college, Key Laboratory of Functional and Clinical Translational Medicine, Fujian Province University, Xiamen Medical and Health Guidance Project.
Abstract (Originalsprache)
Cancer is one of the deadliest diseases to humanity. There is significant progress in treating this disease, but developing some drugs that can fight this disease remains a challenge in the field of medical research. Thirteen new 1,2,3-triazole linked tetrahydrocurcumin derivatives were synthesized by click reaction, including a 1,3-dipolar cycloaddition reaction of tetrahydrocurcumin baring mono-alkyne with azides in good yields, and their in vitro anticancer activity against four cancer cell lines, including human cervical carcinoma (HeLa), human lung adenocarcinoma (A549), human hepatoma carcinoma (HepG2), and human colon carcinoma (HCT-116) were investigated using MTT(3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetraz-olium bromide) assay. The newly synthesized compounds had their structures identified using NMR HRMS and IR techniques. Some of prepared compounds, including compounds 4g and 4k, showed potent cytotoxic activity against four cancer cell lines compared to the positive control of cisplatin and tetrahydrocurcumin. Compound 4g exhibited anticancer activity with a IC50 value of 1.09 ± 0.17 μM against human colon carcinoma HCT-116 and 45.16 ± 0.92 μM against A549 cell lines compared to the positive controls of tetrahydrocurcumin and cisplatin. Moreover, further biological examination in HCT-116 cells showed that compound 4g can arrest the cell cycle at the G1 phase. A docking study revealed that the potential mechanism by which 4g exerts its anti-colon cancer effect may be through inhabiting the binding of APC–Asef. Compound 4g can be used as a promising lead for further exploration of potential anticancer agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Xiamen Medical College, Xiamen 361023, China.
- Xiamen Medical College Research Center for Sustained and Controlled Release Formulations, Xiamen Medical College, Xiamen 361023, China.
- Key Laboratory of Functional and Clinical Translational Medicine, Fujian Province University, Xiamen Medical College, Xiamen 361023, China.
- Department of Medical Biochemical Analysis, College of Health Technology, Cihan University-Erbil, Erbil 44001, Kurdisan Region, Iraq.
- College of Pharmacy, Cihan University-Erbil, Erbil 44001, Kurdisan Region, Iraq.
- Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
ORCID-Profile: Ahmed Mahal, Ahmad J Obaidullah
Förderung
- Science and Technology Project of Xiamen Medical college
- Key Laboratory of Functional and Clinical Translational Medicine, Fujian Province University
- Xiamen Medical and Health Guidance Project
- Fujian Provincial Department of Education Young
Zitieren
APA
Duan, M., Mahal, A., Alkouri, A., Wang, C., Zhang, Z., Ren, J., & Obaidullah, A. J. (2024). Synthesis, Anticancer Activity, and Molecular Docking of New 1,2,3-Triazole Linked Tetrahydrocurcumin Derivatives. Molecules, 29(13), 3010. https://doi.org/10.3390/molecules29133010
Vancouver
Duan M, Mahal A, Alkouri A, Wang C, Zhang Z, Ren J, et al. Synthesis, Anticancer Activity, and Molecular Docking of New 1,2,3-Triazole Linked Tetrahydrocurcumin Derivatives. Molecules. 2024;29(13):3010. doi:10.3390/molecules29133010
BibTeX
@article{Duan2024,
author = {Duan, Meitao and Mahal, Ahmed and Alkouri, Anas and Wang, Chen and Zhang, Zhiqiang and Ren, Jungang and Obaidullah, Ahmad J},
title = {Synthesis, Anticancer Activity, and Molecular Docking of New 1,2,3-Triazole Linked Tetrahydrocurcumin Derivatives},
journal = {Molecules},
year = {2024},
volume = {29},
number = {13},
pages = {3010},
doi = {10.3390/molecules29133010}
}
EUVIMED